Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis
- PMID: 15481608
- PMCID: PMC4531557
- DOI: 10.3904/kjim.2004.19.3.165
Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis
Abstract
Background: Hyperdynamic circulation due to reduced peripheral vascular resistance and increased cardiac output, and the development of portal hypertension are the hemodynamic changes observed in patients with liver cirrhosis. Such hemodynamic abnormalities appear in patients with late stage liver cirrhosis. Therefore, hemodynamic indices, which represent hyperdynamic circulation and portal hypertension, are significant for the prognosis of patients with liver cirrhosis. The aim of this study was to determine the hemodynamic indices associated with the prognosis of patients with liver cirrhosis.
Methods: A total of 103 patients diagnosed with liver cirrhosis between December 1999 and June 2003, with a mean follow-up period of 73 weeks, ranging from 7 to 168 weeks, were recruited. Using Child-Pugh classification, the mean arterial pressure, heart rate and hepatic venous pressure gradient (HVPG) were measured. The indices of Doppler ultrasonography, including the portal and splenic venous flows, and the resistance of the hepatic, splenic, and renal arteries were also measured using the arterial pulsatility index (PI). The prognostic values of these indices were determined by their comparison with the patient survivals.
Results: Significant hemodynamic indices for a bad prognosis were high HVPG (> or = 15 mmHg) and renal arterial PI (> or = 1.14)(p<0.05). A Child-Pugh score > or = 10 was important for a poor prognosis (p<0.05).
Conclusion: Severe portal hypertension (HVPG > or = 15 mmHg) and high renal arterial resistance (PI +/- 1.14) were valuable hemodynamic indices for the prognosis of patients with liver cirrhosis. Therefore, it was concluded that the measurement of these hemodynamic indices, in addition to the Child-Pugh classification, is helpful in the prognosis of patients with liver cirrhosis.
Figures




Similar articles
-
Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.Hepatology. 1996 May;23(5):1035-40. doi: 10.1002/hep.510230515. Hepatology. 1996. PMID: 8621130
-
Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.World J Gastroenterol. 2016 Mar 28;22(12):3441-50. doi: 10.3748/wjg.v22.i12.3441. World J Gastroenterol. 2016. PMID: 27022226 Free PMC article.
-
Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.J Hepatol. 2018 May;68(5):949-958. doi: 10.1016/j.jhep.2017.12.027. Epub 2018 Jan 10. J Hepatol. 2018. PMID: 29331339
-
Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.World J Hepatol. 2015 Mar 27;7(3):607-15. doi: 10.4254/wjh.v7.i3.607. World J Hepatol. 2015. PMID: 25848485 Free PMC article. Review.
-
Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantation.World J Hepatol. 2016 Sep 8;8(25):1047-60. doi: 10.4254/wjh.v8.i25.1047. World J Hepatol. 2016. PMID: 27660671 Free PMC article. Review.
Cited by
-
Vascular Doppler ultrasonographic indices in cirrhosis: a case-control study with emphasis on the common carotid arteries.Radiol Med. 2015 Oct;120(10):982-8. doi: 10.1007/s11547-015-0524-2. Epub 2015 Mar 1. Radiol Med. 2015. PMID: 25725791
-
Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients.J Biomed Sci. 2012 Jul 18;19(1):66. doi: 10.1186/1423-0127-19-66. J Biomed Sci. 2012. PMID: 22809449 Free PMC article.
-
Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients.Saudi J Gastroenterol. 2016 Mar-Apr;22(2):109-15. doi: 10.4103/1319-3767.164185. Saudi J Gastroenterol. 2016. PMID: 26997216 Free PMC article.
-
Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study.PLoS One. 2025 Jun 4;20(6):e0323880. doi: 10.1371/journal.pone.0323880. eCollection 2025. PLoS One. 2025. PMID: 40465795 Free PMC article.
-
Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function.Hepatol Int. 2015 Oct;9(4):621-6. doi: 10.1007/s12072-015-9648-7. Epub 2015 Jul 25. Hepatol Int. 2015. PMID: 26208820
References
-
- Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470. - PubMed
-
- Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001;7:567–580. - PubMed
-
- Jeong EM, Hwang SG, Park HH, Park JH, Kim HT, Oh SW, Kho KH, Hong SP, Park PW, Rim GS, Kim SH. The anayisis of mortality rate according to CTP sand MELD score in patients with liver cirrhosis. Korean J Hepatol. 2003;9:98–106. - PubMed
-
- Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlicb J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjuguiar intrahepatic portosystemic shunt. Gut. 2003;52:879–885. - PMC - PubMed
-
- Lee DH, Son JH, Kim TW. New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score. Korean J Hepatol. 2003;9:167–179. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous